Skip to content
Clinical Trials – home
Research site

Hautaerzte Zentrum Hannover GbR

Germany Osterstrasse 24, 30159 Hanover, Germany

  • Hidradenitis
  • Adult patients

About Specializations

Hautaerzte Zentrum Hannover GbR in Hanover, Germany specialises in clinical trials of conditions such as Hidradenitis, and other specialisations. This site conducts important research.

Main research areas of the site

Dermatology and Immunology

The medical center is at the forefront of dermatology and immunology, focusing on innovative treatments for chronic skin conditions. The ongoing research into Hidradenitis Suppurativa highlights the center's commitment to improving patient outcomes through advanced therapeutic strategies.

  • Hidradenitis Suppurativa
  • Chronic Skin Conditions
  • Immunomodulatory Therapies

By evaluating the long-term safety and efficacy of novel treatments like Bimekizumab, the center contributes significantly to the understanding and management of complex dermatological disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Osterstrasse 2430159 HanoverGermany
Recruiting now
no trials
Conditions studied
1

More sites in HanoverGermany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bimekizumab
  • Sponsor:UCB Biopharma

Hidradenitis

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
  • Sponsor:Incyte Corp.

Hidradenitis

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
  • Sponsor:Incyte Corp.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.